A Behavioral Slow-Breathing Exercise Program for Female Overactive Bladder
针对女性膀胱过度活动症的行为慢呼吸锻炼计划
基本信息
- 批准号:9027790
- 负责人:
- 金额:$ 46.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-15 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdherenceAdultAdverse effectsAffectAnti-CholinergicsAnxietyAnxiety DisordersAutonomic nervous systemBehavior TherapyBehavioralBladderBreathingBreathing ExercisesCholinergic AgentsChronicClinical TrialsCommunitiesDevicesEducational process of instructingEquilibriumEsthesiaExerciseExtravasationFDA approvedFemaleFrequenciesFunctional disorderGoalsHealthHome environmentHypertensionIncontinenceInterventionLinkMeasuresMediatingMediator of activation proteinMuscle ContractionNervous System controlOveractive BladderPamphletsParticipantPatient Self-ReportPatientsPharmaceutical PreparationsPhysiologicalPredispositionQuality of lifeQuestionnairesRandomizedRandomized Controlled TrialsRecurrenceReportingResearchRespirationRestSelf ManagementSeveritiesStressSymptomsSyndromeTechniquesTimeUrinationUrineWomananxiety symptomsassociated symptomclinical anxietydesigndiariesexercise programexperienceheart rate variabilityimprovedinsightintervention effectnovelnovel strategiespilot trialrandomized trialrespiratoryresponsetherapy designtreatment as usualtreatment effecttreatment programtrend
项目摘要
DESCRIPTION (provided by applicant): Overactive bladder (OAB), a syndrome defined by recurring strong urges to urinate, frequent trips to the bathroom, and in some cases involuntary urine leakage, affects up to one in five adult women and can have a profound effect on women's day-to-day activities and quality of life. Existing treatments for OAB, such as anti- cholinergic drugs, are associated with multiple side effects or have other limitations that limit their usefulness or result in high rates of discontinuation in the community. Because OAB is associated with increased levels of self-reported anxiety and perceived stress, as well as abnormalities in autonomic nervous system control that are linked with anxiety disorders, behavioral interventions that decrease anxiety and improve autonomic control offer a potentially novel approach to treating this condition. We previously examined the feasibility of teaching women with OAB symptoms to practice slow-paced respiration, a behavioral technique that involves slowing the resting breathing rate to 5 to 10 breaths per minute to improve autonomic balance. Women were assigned to practice slow-breathing exercises for approximately 15 minutes a day at home for 6 weeks using a small, commercially-available guided-breathing device that is currently FDA-approved for treatment of other conditions associated with autonomic nervous system imbalance (i.e., hypertension). In our pilot trial, recruitment of women was rapid, completion of home slow-breathing exercise sessions was high, and participants randomized to the slow-breathing intervention showed a promising trend toward reduction in OAB-related urine leakage compared to usual care. To rigorously evaluate the effects of this intervention on OAB syndrome, we propose to conduct a 12-week randomized controlled trial, in which 160 women with OAB will be randomized to: 1) use a standard guided- breathing device to practice slowing their breathing rate to 5 to 10 breaths per minute for at leas 15 minutes per day, or 2) use an identical-appearing control device that allows them to breathe at a normal rate of 14 breaths per minute. All women will complete symptom diaries and questionnaires to document OAB symptoms, undergo measures of autonomic function, and complete questionnaires about anxiety and stress. Our goals are to: 1) determine whether the proposed slow-breathing exercise program is effective in reducing the severity of OAB symptoms in women; 2) determine whether this slow-breathing intervention is effective in improving autonomic nervous system control and examine change in autonomic function as a mediator of treatment effects on OAB; and 3) determine whether this slow-breathing intervention is effective in improving anxiety symptoms and explore improvement in anxiety as a mediator of treatment effects on OAB. This study has the potential to significantly advance treatment of OAB in women, as well as change current research paradigms regarding this widely prevalent health problem.
描述(由申请人提供):膀胱过度活动症(OAB)是一种由反复强烈的排尿冲动、频繁上厕所以及在某些情况下非自愿尿漏定义的综合征,影响多达五分之一的成年女性,并可能对女性的日常活动和生活质量产生深远影响。OAB的现有治疗(如抗胆碱能药物)与多种副作用相关,或具有限制其有效性或导致社区中高停药率的其他限制。由于OAB与自我报告的焦虑和感知压力水平增加以及与焦虑症相关的自主神经系统控制异常有关,因此减少焦虑和改善自主控制的行为干预提供了治疗这种疾病的潜在新方法。我们之前研究了教导患有OAB症状的女性练习慢节奏呼吸的可行性,这是一种行为技术,涉及将静息呼吸速率减慢至每分钟5至10次呼吸,以改善自主平衡。女性被分配在家中每天练习大约15分钟的缓慢呼吸练习,持续6周,使用目前FDA批准用于治疗与自主神经系统失衡相关的其他病症(即,高血压)。在我们的试点试验中,招募妇女的速度很快,完成家庭慢呼吸运动课程的比例很高,随机分配到慢呼吸干预的参与者显示出与常规护理相比,OAB相关的尿漏减少的趋势。为了严格评估这种干预对OAB综合征的影响,我们建议进行一项为期12周的随机对照试验,其中160名OAB女性将被随机分配到:1)使用标准的引导呼吸装置来练习将他们的呼吸速率减慢到每分钟5到10次呼吸,每天至少15分钟,或2)使用一个外观相同的控制装置,使他们能够以每分钟14次呼吸的正常速率呼吸。所有女性都将完成症状日记和问卷调查,以记录OAB症状,进行自主神经功能的测量,并完成有关焦虑和压力的问卷调查。我们的目标是:1)确定所提出的慢呼吸锻炼计划是否有效地降低女性OAB症状的严重程度; 2)确定这种慢呼吸干预是否有效地改善自主神经系统控制,并检查自主功能的变化作为对OAB的治疗效果的中介;以及3)确定这种缓慢呼吸干预是否有效地改善焦虑症状,并探索焦虑的改善作为OAB治疗效果的中介。这项研究有可能显着推进女性OAB的治疗,并改变目前关于这一广泛流行的健康问题的研究范式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison Huang其他文献
Alison Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison Huang', 18)}}的其他基金
Letrozole for Treatment of Uterine Fibroids: A randomized, placebo-controlled trial
来曲唑治疗子宫肌瘤:一项随机、安慰剂对照试验
- 批准号:
10718036 - 财政年份:2023
- 资助金额:
$ 46.95万 - 项目类别:
Promoting Clinical and Translational Science Training and Career Development for Residents
促进住院医师的临床和转化科学培训和职业发展
- 批准号:
10598346 - 财政年份:2023
- 资助金额:
$ 46.95万 - 项目类别:
Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹
- 批准号:
10343015 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Language-Concordant Mobile Health Training and Support for Behavioral Management of Urinary Incontinence for Women with Limited English Proficiency
为英语水平有限的女性提供语言一致的移动健康培训和尿失禁行为管理支持
- 批准号:
10772574 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence Administrative supplement
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹行政补充
- 批准号:
10635598 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Cognitive, urinary, and functional trajectories of older women using pharmacologic treatment strategies for urgency incontinence
使用药物治疗策略治疗急迫性尿失禁的老年女性的认知、泌尿和功能轨迹
- 批准号:
10563201 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Promoting Multidisciplinary Clinical and Translational Science in Aging by Resident Investigators
常驻研究人员促进老龄化领域的多学科临床和转化科学
- 批准号:
10333347 - 财政年份:2021
- 资助金额:
$ 46.95万 - 项目类别:
Promoting Multidisciplinary Clinical and Translational Science in Aging by Resident Investigators
常驻研究人员促进老龄化领域的多学科临床和转化科学
- 批准号:
10557121 - 财政年份:2021
- 资助金额:
$ 46.95万 - 项目类别:
Midcareer Mentoring in Patient-Oriented Research on Genitourinary Aging in Women
以患者为导向的女性泌尿生殖系统衰老研究中的职业生涯中期指导
- 批准号:
10040999 - 财政年份:2020
- 资助金额:
$ 46.95万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 46.95万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 46.95万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 46.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 46.95万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 46.95万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 46.95万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 46.95万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 46.95万 - 项目类别: